Reach Our XS™ Technology Experts:

xstechnologies@lonza.com  

Download Our XS™ Technologies Brochure

Embracing Complexity

Based on 30 years of innovation in microbial biotechnology, Lonza offers the XS™ Microbial Expression Technologies Portfolio, an advanced and versatile production platform for biological candidates.

No single host type or vector is capable of being the best expression option for all types of biotherapeutics and vaccines. Therefore, Lonza has assembled a collection of proprietary expression systems that are screened in a high throughput manner to identify the best production clone for your product.

Various E. coli options form the foundation of Lonza's XS™ Technologies and are complemented by several host options, including P. pastoris (Pichia) and B. subtilis (Bacillus).

In combination with our upstream and downstream production platforms, our XS™ Technologies quickly deliver cGMP processes that are:

    • Productive
    • Robust
    • Scalable
    • Efficient

 

The benefits of XS™ Technologies can be explored in two ways:  Lonza offers a complete range of strain development services in Visp, Switzerland and XS™ Technologies are available for use is your own labs under a Research Evaluation Agreement (REA).

 

 

To learn more about our diverse XS™ Technology Toolbox from an industry expert, please download Dr. Joachim Klein's webinar entitled, "Using the XS Toolbox to Optimize Strain Design and Development."